Determinants of Covid-19 Vaccinations among Slum Dwellers: A Case of Katanga, Kampala, Uganda

Abstract:
Coronavirus Disease of 2019
(COVID-19) is caused by the Severe Acute Respiratory Syndrome coronavirus
2(SARS-COV-2). The SARS-COV-2 is a β-coronavirus , which is non-segmented
positive-sense RNA virus. The symptoms of COVID-19 may vary. The study was
carried out to; examine the individual determinants and socioeconomic
determinants and to describe the Health-system determinants of COVID-19
vaccination among Residents of Katanga Slum. The individual determinants were;
age between 26 to 35 years (AOR=4.502, CI=1.706-11.886, P=0.002), sex; being of
male gender (AOR=2.267, CI=1.316-5.443, P=0.007), marital status; being single
(AOR=0.334, CI=0.136-0.820, P=0.017), Being with primary level of education
(AOR=17.707, CI=2.393-130.99, P=0.005), occupation; being a peasant (AOR=4.857,
CI=1.232-19.14, p=0.024), religion; being a catholic (COR=0.411,
CI=0.200-0.846, P-0.016), utilization of health facility for health care
(COR=0.047, CI=0.014-0.162, P=0.000) and having a negative attitude towards
COVID 19 vaccination (AOR=42.637, CI=320.65, P=0.000). The socio-economic
factors were; income (x2=18.861, p=0.000), cost of transport (x2=19.492,
p=0.000), cost of vaccination (x2=124.34, p=0.000) and the type of social class
of respondents (x2=23.73, p=0.000). In multivariate analysis; only work effect
was a determinant of COVID-19 vaccination (AOR=0.327, CI=0.127-0.847 and
p=0.021). The health facility determinants were; sensitization (AOR=1.889,
CI=1.040-3.431, P=0.037), availability of health workers at facility
(AOR=0.211, CI=0.04-0.006, P=0.012), attitudes of health workers (AOR=79.97,
CI=11.49-556.3, P=0.000), and Availability of COVID 19 vaccines at the health
facility (AOR=0.054, CI=0.006-0.514, P=0.011). The study recommended Increased
and continued sensitization for awareness promotion towards the benefits of
uptake of COVID-19 vaccination as well as the associated dangers of
non-compliance.
References:
[1].
Rothan, H.A. and S.N.
Byrareddy, The epidemiology and pathogenesis of coronavirus disease (COVID-19)
outbreak. Journal of Autoimmunity, 2020. 109: p. 102433.
[2].
Cucinotta, D. and M.
Vanelli, WHO Declares COVID-19 a Pandemic. Acta Biomed, 2020. 91(1): p.
157-160.
[3].
Guo, Y.-R., et al., The
origin, transmission and clinical therapies on coronavirus disease 2019
(COVID-19) outbreak–an update on the status. Military Medical Research,
2020. 7: p. 1-10.
[4].
Kaplan, A.K., et al., The
willingness to accept the COVID‐19 vaccine and affecting factors among healthcare
professionals: A cross‐sectional study in Turkey. International
Journal of Clinical Practice, 2021: p. e14226.
[5].
UNICEF and GAVI Uganda
receives 864,000 doses of COVID-19 vaccines. 2021.
[6].
Ministry of Health Uganda
COVID-19 status. 2021.
[7].
Wang, C., et al., A novel
coronavirus outbreak of global health concern. The Lancet, 2020.
395(10223): p. 470-473.
[8].
Gong, F., et al., China’s
local governments are combating COVID-19 with unprecedented responses—from a
Wenzhou governance perspective. Frontiers of Medicine, 2020: p. 1-5.
[9].
Coe, P.F., L.L. Graper, and
C.M. Zangerle, Leading Through the Unknown: A Network Perspective of the
COVID-19 Pandemic. Critical Care Nursing Quarterly, 2020. 43(4): p.
451-467.
[10]. Snyder, T.M., et al., Magnitude and dynamics of the
T-cell response to SARS-CoV-2 infection at both individual and population
levels. MedRxiv, 2020.
[11]. Wu, S.C., Progress and concept for COVID‐19 vaccine development. Biotechnology
Journal, 2020.
[12]. UNICEF Uganda receives the first batch of AstraZeneca
COVID-19 vaccines. 2021.
[13]. Sun, S., D. Lin, and D. Operario, Interest in COVID-19
vaccine trials participation among young adults in China: Willingness, reasons
for hesitancy, and demographic and psychosocial determinants. Preventive Medicine
Reports, 2021. 22: p. 101350.
[14]. Reiter, P.L., M.L. Pennell, and M.L. Katz, Acceptability
of a COVID-19 vaccine among adults in the United States: How many people would
get vaccinated? Vaccine, 2020. 38(42): p. 6500-6507.
[15]. Kreps, S., et al., Factors associated with US adults’
likelihood of accepting COVID-19 vaccination. JAMA network open, 2020.
3(10): p. e2025594-e2025594.
[16]. Guidry, J.P., et al., Willingness to get the COVID-19
vaccine with and without emergency use authorization. American Journal of Infection
Control, 2021. 49(2): p. 137-142.
[17]. Li, P., et al., Analysis of factors influencing parents’
willingness to accept the quadrivalent influenza vaccine for school-aged
children in the Nanhai District, China. Human Vaccines & Immunotherapeutics,
2020. 16(5): p. 1078-1085.
[18]. UNICEF Uganda launches first phase of COVID-19
vaccination exercise. 2021.
[19]. Akinyemi, P.A., et al., Community perception and
determinants of willingness to uptake COVID-19 vaccines among residents of Osun
State, South-West Nigeria. International Journal of Community Medicine and
Public Health, 2021. 8(4): p. 1551.
[20]. Echoru, I., P. Decanar Ajambo, and E. Bukenya,
Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional
Study in Western Uganda. 2020.
[21]. Daama, A., et al., Willingness to receive COVID-19
vaccines, associated factors and reasons for not taking a vaccine: a cross
sectional study among persons aged 13–80 years in Wakiso, Central Uganda. BMC
Infectious Diseases, 2024. 24(1): p. 391.
[22]. King, P., et al., COVID-19 vaccine uptake and coverage,
Uganda, 2021-2022. UNIPH Bulletin, 2023. 8.
[23]. Kasozi, K.I., et al., A Descriptive-Multivariate
Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical
Trials among Healthcare Workers in Uganda. Vaccines, 2021. 9(3): p. 253.
[24]. Peretti-Watel, P., et al., A future vaccination campaign
against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet
infectious diseases, 2020. 20(7): p. 769-770.
[25]. Mathpati, M.M., et al., ‘Population Self-Reliance in
Health’and COVID 19: the need for a 4th Tier in the Health System. Journal
of Ayurveda and Integrative Medicine, 2020.
[26]. Kish, L., Sampling organizations and groups of unequal
sizes. American Sociological Review, 1965: p. 564-572.
[27]. Creswell, J.W., Qualitative inquiry and research design:
Choosing among five traditions. Qualitative inquiry and research design:
Choosing among five traditions. 1998, Thousand Oaks, CA, US: Sage
Publications, Inc. xv, 403-xv, 403.
[28]. Kuter, B.J., et al., Perspectives on the receipt of a
COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia.
Vaccine, 2021. 39(12): p. 1693-1700.
[29]. Browne, N.T., et al., When pandemics collide: the impact
of COVID-19 on childhood obesity. Journal of pediatric nursing, 2021.
56: p. 90.
[30]. Nzaji, M.K., et al., Factors associated with COVID-19
vaccine uptake and hesitancy among healthcare workers in the Democratic
Republic of the Congo. PLOS Global Public Health, 2024. 4(2): p.
e0002772.
[31]. Qattan, A.M., et al., Acceptability of a COVID-19
vaccine among healthcare workers in the Kingdom of Saudi Arabia. Frontiers
in medicine, 2021. 8: p. 644300.
[32]. Dror, A.A., et al., Vaccine hesitancy: the next
challenge in the fight against COVID-19. European journal of epidemiology,
2020. 35(8): p. 775-779.
[33]. Echoru, I., et al., Sociodemographic factors associated
with acceptance of COVID-19 vaccine and clinical trials in Uganda: a
cross-sectional study in western Uganda. BMC public health, 2021. 21(1):
p. 1106.
[34]. Paudel, P., Online education: Benefits, challenges and
strategies during and after COVID-19 in higher education. International
Journal on Studies in Education (IJonSE), 2021. 3(2).
[35]. Ruiz, J.B. and R.A. Bell, Predictors of intention to
vaccinate against COVID-19: Results of a nationwide survey. Vaccine,
2021. 39(7): p. 1080-1086.
[36]. Barry, M., M. Al Amri, and Z.A. Memish, COVID-19 in the
shadows of MERS-CoV in the Kingdom of Saudi Arabia. Journal of epidemiology
and global health, 2020. 10(1): p. 1-3.
[37]. Pradhan, A. and P.-E. Olsson, Sex differences in
severity and mortality from COVID-19: are males more vulnerable? Biology of
sex Differences, 2020. 11(1): p. 53.
[38]. Kanyike, A.M., et al., Acceptance of the coronavirus
disease-2019 vaccine among medical students in Uganda. Tropical Medicine and
Health, 2021. 49(1): p. 37.
[39]. Wang, H., et al., The psychological distress and coping
styles in the early stages of the 2019 coronavirus disease (COVID-19) epidemic
in the general mainland Chinese population: A web-based survey. PloS one,
2020. 15(5): p. e0233410.
[40]. Bitar, A.N., et al., Misinformation, perceptions towards
COVID-19 and willingness to be vaccinated: a population-based survey in Yemen. PLoS
One, 2021. 16(10): p. e0248325.
[41]. De Figueiredo, A., et al., Mapping global trends in
vaccine confidence and investigating barriers to vaccine uptake: a large-scale
retrospective temporal modelling study. The Lancet, 2020. 396(10255): p.
898-908.
[42]. Jegede, A.S., What led to the Nigerian boycott of the
polio vaccination campaign? PLoS medicine, 2007. 4(3): p. e73.
[43]. Machida, M., et al., Acceptance of a COVID-19 Vaccine in
Japan during the COVID-19 Pandemic. Vaccines, 2021. 9(3): p. 210.
[44]. Jain, J., et al., COVID-19 vaccine hesitancy among
medical students in India. Epidemiology & Infection, 2021. 149: p.
e132.
[45]. Bongomin, F., et al., COVID-19 vaccine acceptance among
high-risk populations in Uganda. Therapeutic Advances in Infectious Disease,
2021. 8: p. 204993612110243.
[46]. Chou, W.-Y.S. and A. Budenz, Considering emotion in
COVID-19 vaccine communication: addressing vaccine hesitancy and fostering
vaccine confidence. Health communication, 2020. 35(14): p. 1718-1722.
[47]. Samarasekera, U., Feelings towards COVID-19 vaccination
in Africa. The Lancet Infectious Diseases, 2021. 21(3): p. 324.
[48]. Campo-Arias, A. and J.C. Pedrozo-Pupo, COVID-19 vaccine
distrust in Colombian university students: Frequency and associated variables. Acta
Biomed, 2022. 92(6): p. e2021367.
[49]. Ohemeng-Tinyase, N.A., Factors Associated with Hepatitis
B Vaccination Among Asian Adults (≥ 18 Years) in the United
States. 2020, Walden University.
[50]. Endalew, M., et al., Limited handwashing facility and
associated factors in sub-Saharan Africa: pooled prevalence and multilevel
analysis of 29 sub-Saharan Africa countries from demographic health survey
data. BMC Public Health, 2022. 22(1): p. 1969.
[51]. Schmidt, C.W., Lack of Handwashing Access: A Widespread
Deficiency in the Age of COVID-19. Environ Health Perspect, 2020.
128(6): p. 64002.
[52]. Malande, O.O., et al., Barriers to effective uptake and
provision of immunization in a rural district in Uganda. PloS one, 2019.
14(2): p. e0212270.
[53]. Azodo, C., et al., Hepatitis-B vaccination status among
dental surgeons in benin city, Nigeria. Ann Med Health Sci Res, 2012.
2(1): p. 24-8.